Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase I clinical study of FOL-014 for Diabetes mellitus

Next Previous
Trial Profile

A phase I clinical study of FOL-014 for Diabetes mellitus

Status: Suspended
Phase of Trial: Phase I

Latest Information Update: 21 Sep 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs FOL 014 (Primary)
  • Indications Diabetes mellitus
  • Focus Adverse reactions

Most Recent Events

  • 15 Sep 2021 Status changed from planning to suspended as the company had paused all drug development projects against hair loss and diabetic complications and evaluates opportunities to utilize the companys tissue repairing peptides and unique formulation technology in other disease areas according to a Follicum AB media release
  • 22 Jun 2020 According to a Follicum AB media release, the company expects to initiate this study in 2021.
  • 28 May 2019 New trial record

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top